LEONA GILLESPIE: Open Payments
NPI 1134397334 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 32 payments from 8 companies in 2025. Trend: 2023 $1,031 · 2024 $1,323 · 2025 $832
Food & beverage: $611Education: $221
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $294 |
| Janssen Pharmaceuticals, Inc | 9 | $173 |
| E.R. Squibb & Sons, L.L.C. | 5 | $148 |
| Alkermes, Inc. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $14 |
Products named: INVEGA SUSTENNA, COBENFY, UZEDY, ARISTADA, ABILIFY ASIMTUFII, FANAPT, INGREZZA, VRAYLAR.
Industry payments across AK — which companies pay providers there.
